RNA-transfected dendritic cells

References

• Gilboa E. Immunotherapy of cancer with genetically modified tumor vaccines. Seminars in Oncology23, 101–107 (1996).
   Web of Science ®Google Scholar
• Huang AY, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H. Role of bone marrow-derived cells in presenting MHC class I- restricted tumor antigens. Science 264,961–965 (1994).
   PubMed Web of Science ®Google Scholar
• Banchereau J, Briere F, Caux C et al Immunobiology of dendritic cells. Ann. Rev Immuno118, 767–811 (2000).
   Google Scholar
• Inaba K, Inaba M, Romani N et al Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/ macrophage colony-stimulating factor. Exp. Med 176,1693–1702 (1992).
   PubMed Web of Science ®Google Scholar
• Romani N, Gruner S, Brang D et al Proliferating dendritic cell progenitors in human blood. I Exp. Med 180,83–93 (1995).
   Google Scholar
• Boon T, van der Bruggen P Human tumor antigens recognized by T-lymphocytes. Exp. Med 183,725–729 (1996).
   PubMed Web of Science ®Google Scholar
• Houghton A. Cancer antigens: immune recognition of self and altered self. j Exp. Med 180,1–4 (1994).
   PubMed Web of Science ®Google Scholar
• Strobel I, Berchtold S, Gotze A, Schulze U, Schuler G, Steinkasserer A. Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein Ml differ in their ability to stimulate cytotoxic T-lymphocytes. Gene Ther 7, 2028–2035 (2000).
   PubMed Web of Science ®Google Scholar
• Boczkowski D, Nair SK, Snyder D, Gilboa E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in viva .1. Exp. Med 184,465–472 (1996).
   Google Scholar
• •First paper to demonstrate the efficacy of RNA-pulsed DCs.
   Google Scholar
• Nair S, Zhou F, Reddy R, Huang L, Rouse BT Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T-lymphocyte responses in vitra I Exp. Med 175,609–612 (1992).
   Google Scholar
• Mayordomo JI, Loftus DJ, Sakamoto H etal. Therapy of murine tumors with p53 wild type and mutant sequence peptide-based vaccines. j Ew. Med. 183(4), 1357–1365 (1996).
   Google Scholar
• Paglia P, Chiodoni C, Rodolfo M, Colombo MP. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T-lymphocytes against tumor antigen in vivo. j Exp. Med. 183(1), 317–322 (1996).
   Google Scholar
• Gilboa E. The makings of a tumor rejection antigen. Immunity 11,263–270 (1999).
   PubMed Web of Science ®Google Scholar
• Ludewig B, McCoy K, Pericin M et al Rapid peptide turnover and inefficient presentation of exogenous antigen critically limit the activation of self-reactive CTL by dendritic cells. j Immunol 166(6), 3678–3687 (2001).
   PubMed Web of Science ®Google Scholar
• Bennett SR, Carbone FR, Karamalis F, Miller JF, Heath WR. Induction of a CD8+ cyt.otoxic T-lymphocyte response by cross-priming requires cognate CD4+ T-cell help. I Exp. Med. 186(1), 65–70 (1997).
   Google Scholar
• Faiola B, Doyle C, Gilboa E, Nair S. Influence of CD4 T-cells and the source of major histocompatibility complex class II-restricted peptides on cytotoxic T-cell priming by dendritic cells. Immunology 106(1), 122–123 (2002).
   Google Scholar
• Keene J, Forman J. Helper activity is required for the in vivo generation of cytotoxic T-lymphocytes. I Exp. Med 155, 768–782 (1982).
   PubMed Web of Science ®Google Scholar
• Nair SK, Boczkowski D, Morse M, Cumming RI, Lyerly HK, Gilboa E. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocytes in vitm using human dendritic cells transfected with RNA. Nat. Biotechnol 16,364–369 (1998).
   PubMed Web of Science ®Google Scholar
• •First paper to use human DCs transfected with RNA to stimulate a immune response.
   Google Scholar
• Arthur JF, Butterfield LH, Roth MD et al A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther. 4, 17–25 (1997).
   PubMed Web of Science ®Google Scholar
• Van Tendeloo VF, Ponsaerts P, Lardon F et al Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. B/ooc/98(1), 49–56 (2001).
   Google Scholar
• Nikitina EY, Clark JI, Van Beynen J et al Dendritic cells transduced with full-length wild type p53 generate antitumor cytotoxic T-lymphocytes from peripheral blood of cancer patients. Clin. Cancer Res. 7(1), 127–135 (2001).
   Google Scholar
• Ashley DM, Faiola B, Nair S, Hale LP, Bigner DD, Gilboa E. Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. j Exp. Med 186(7), 1177–1182 (1997).
   Google Scholar
• Nair SK, Boczkowski D, Snyder D, Gilboa E. Antigen-presenting cells pulsed with unfractionated tumor-derived peptides are potent tumor vaccines. Eur j Immunol 27(3), 589–597 (1997).
   Google Scholar
• Boczkowski D, Nair SK, Nam J, Lyerly HK, Gilboa E. Induction of tumor immunity and cytotoxic T-lymphocyte responses using dendritic cells transfected with mRNA amplified from tumor cells. Can. Res. 60,1028–1034 (2000).
   Google Scholar
• Hoerr I, Obst R, Rammensee H-G, Jung G, In vivo application of RNA leads toinduction of specific cytotoxic T-lymphocytes and antibodies. Eur. Immunol 30,1–7 (2000).
   PubMed Web of Science ®Google Scholar
• Zhang W He L, Yuan Z et al Enhanced therapeutic efficacy of tumor RNA-pulsed dendritic cells after genetic modification with lymphotactin. Hum. Gene Ther 10, 1151–1161 (1999).
   Google Scholar
• Insug O, Ku G, Ertl HC, Blaszczyk-Thurin M. A dendritic cell vaccine induces protective immunity to intracranial growth of glioma. AntiCancer Res. 22(2A), 613–621 (2002).
   Google Scholar
• Koido S, Kashiwaba M, Chen D, Gendler S, Kufe D, Gong J. Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA. I Immunol 165(10), 5713–5719 (2000).
   Google Scholar
• Bacci A, Montagnoli C, Perruccio K et al. Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation. Immunol 168(6), 2904–2913 (2002).
   Google Scholar
• Thornburg C, Boczkowski D, Gilboa E, Nair SK. Induction of cytotoxic T-lymphocytes with dendritic cells transfected with human papillomavirus E6 and E7 RNA: implications for cervical cancer immunotherapy. Immunother 23(4), 4121–418 (2000).
   Google Scholar
• Su Z, Peluso MV, Raffegerst SH, Schendel DJ, Roskrow MA. The generation of LMP2a-specific cytotoxic T-lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease. Eur. Immunol 3,947–958 (2001).
   Google Scholar
• Nair SK, Heiser A, Boczkowski D et al Induction of cytotoxic T-cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. Nat. Med. 6(9), 1011–1017 (2000).
   PubMed Web of Science ®Google Scholar
• Saeboe-Larssen S, Fossberg E, Gaudernack G. mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T-lymphocyte responses against the telomerase catalytic subunit (hTERT). I Immunol Mthods259(1-2), 191–203 (2002).
   Google Scholar
• Su Z, Vieweg J, Weizer A et al. Enhanced induction of telomerase-specific CD4+ T-cells using dendritic cells transfected with RNA encoding a chimeric gene product. Cancer Res. 62(17), 5041–5048 (2002).
   Google Scholar
• Kalady MF, Onaitis MW, Padilla KM, Emani S, Tyler DS, Pruitt SK. Enhanced dendritic cell antigen presentation in RNA-based immunotherapy. I Surg. Res. 105(1), 17–24 (2002).
   Google Scholar
• Weissman D, Ni H, Scales D et al HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation and induces a potent human in vitro primary immune response. J. Immunol 165(8), 4710–4717 (2000).
   PubMedGoogle Scholar
• Heiser A, Coleman D, Dannull J etal. Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. Clin. Invest. 109(3), 409–417 (2002). Study showing immune responses in prostate cancer patients.
   Google Scholar
• Ni H, Capodici J, Cannon G et al Extracellular mRNA induces dendritic cell activation by stimulating tumor necrosis factor-alpha secretion and signaling through a nucleotide receptor. J Biol. Chem. 277(15), 12689–12696 (2002).
   Google Scholar
• Heiser A, Maurice MA, Yancey DR, Coleman DM, Dahm P, Vieweg J. Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors. Cancer Res. 61(8), 3388–3393 (2001).
   Google Scholar
• Heiser A, Maurice MA, Yancey DR et al Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA. J. Immunol 166(5), 2953–2960 (2001).
   PubMed Web of Science ®Google Scholar
• Rains N, Cannan RJ, ChenW, Stubbs RS. Development of a dendritic cell (DC)-based vaccine for patients with advanced colorectal cancer. Hepatogastroenterology 48(38), 347–351 (2001).
   PubMed Web of Science ®Google Scholar
• Ponsaerts P, Van den Bosch G, Cools N et al Messenger RNA electroporation of human monocytes followed by rapid in vitro differentiation, leads to highly stimulatory antigen-loaded mature dendritic cells. J Immunol 169,1669–1675 (2002).
   PubMed Web of Science ®Google Scholar
• Ponsaerts P, Van Tendeloo VFI, Cools N et al mRNA-electroporated mature dendritic cells retain transgene expression, phenotypical properties and stimulatory capacity after cryopreservation. Leukemia 16,1324–1330 (2002).
   PubMed Web of Science ®Google Scholar
• Nair SK, Hull S, Coleman D, Gilboa E, Lyerly HK, Morse M. Induction of carcinoembryonic antigen (CEA)-specific CTL responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA. Int. J Cancer 82,121–124 (1999).
   PubMed Web of Science ®Google Scholar
• Eppler E, Honig, Kaufman HL, Groscurth P, Filgueira L. Carcinoembryonic antigen (CEA) presentation and specific T-cell-priming by human dendritic cells transfected with CEA-mRNA. Eur Cancer38, 184–193 (2002).
   Google Scholar
• Nair SK, Morse M, Boczkowski D et al 2002. Induction of tumor-specific cytotoxic T-lymphocytes in cancer patients by autologous tumor RNA transfected dendritic cells. Ann. Surgery 235 (4), 540–549 (2002).
   Google Scholar
• Heiser, A, Dahm P, Yancey D et al Human dendritic cells (DC) transfected with RNA encoding prostate specific antigen (PSA) stimulate prostate specific CTL responses in Wm I Immunol 164,5508–5514 (2000).
   Google Scholar
• Ziske C, Marten A, Schatker B et al Resistance of pancreatic carcinoma cells is reversed by coculturing NK-like T-cells with dendritic cells pulsed with tumor-derived RNA and CA 19–9. Molecular Ther. 3(1), 54–60 (2001).
   Google Scholar
• Schmitt WE, Stassar MJJG, Schmitt W Little M, Cochlovius B. In vitro induction of a bladder cancer-specific T-cell response by mRNA-transfected dendritic cells. J Cancer Res. Clin. Oncol 127,203–206 (2001).
   Google Scholar